7 Results for "

scopolamine-induced amnesia

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "scopolamine-induced amnesia" in MCE Product Catalog:

Cat. No.: HY-14840
CAS No.: 77472-70-9
Purity:  99.58%
Synonyms: Carphedon
Phenylpiracetam (Carphedon) is a positive allosteric modulator of nicotinic acetylcholine receptors (nAChR) with an IC50 of 5.86 μM. Phenylpiracetam is applicable to studies on scopolamine (Scopolamine) (HY-N0296)-induced amnesia, depression and immune stress .
loading...
    loading...
Cat. No.: HY-149776
CAS No.: 2408799-43-7
Target:  

nAChR

Research Areas:  

Neurological Disease

RGH-560 (compound 53) shows highly advanced α7 nAChR positive modulator properties and favorable physicochemical features. RGH-560 has robust procognitive in vivo potential. RGH-560 can be used to study Scopolamine (HY-N0296) -induced amnesia in mice .
loading...
    loading...
Cat. No.: HY-149287
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

hAChE/hBACE-1-IN-1 (compounds 5d) is an orally active inhibitor of hAChE with blood-brain permeability. hAChE/hBACE-1-IN-1 inhibits hAChE and hBACE-1 with IC50 values of 0.076 and 0.23 μM, respectively. hAChE/hBACE-1-IN-1 inhibits Aβ1-42 aggregation and improves mouse learning and memory ability. hAChE/hBACE-1-IN-1 can be used to research in Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-149288
hAChE/hBACE-1-IN-2 is a potent, orally active, blood-brain barrier transboundary triple inhibitor of hAChE, hBChE, and HACE-1 with IC50s of 0.113 μM, 1.48 μM and 0.38 μM, respectively. hAChE/hBACE-1-IN-2 has antioxidant activity. hAChE/hBACE-1-IN-2 also inhibits Aβ11-42 aggregation. hAChE/hBACE-1-IN-2 can be used to study Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-180891
Multitarget AD-IN-4 (compound IIIj) is a multitarget-directed ligand (MTDL), with the ability to simultaneously inhibit ChE enzymes (EeAChE IC50 = 0.157 μM, eqBuChE IC50 = 0.147 μM, hAChE IC50 = 1.551 μM, hBuChE IC50 = 2.152 μM), exhibit antioxidant activity, provide neuroprotection, and inhibit calcium channels (Ca 2+ channel blockade: IC50 = 30.59 μM). Multitarget AD-IN-4 reverses Scopolamine (HY-N0296)-induced amnesia in a mouse model. Multitarget AD-IN-4 can be used for Alzheimer’s disease (AD) research .
loading...
    loading...
Cat. No.: HY-130235
CAS No.: 58033-22-0
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Naprodoxime hydrochloride is a derivative of Piracetam (HY-B0585). Naprodoxime hydrochloride acts as a potent antidepressant and anti-aggressive agent .
loading...
    loading...
Cat. No.: HY-105461
CAS No.: 154619-51-9
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

MF 268 is an orally active, blood-brain barrier-permeable acetylcholinesterase (AChE) inhibitor with an IC50 of 9 nM in rats. MF 268 binds to both the catalytic site and the regulatory anionic site of acetylcholinesterase, and increases the extracellular levels of acetylcholine, norepinephrine, dopamine and serotonin in the rat cortex via a dose-dependent pathway. MF 268 exhibits anti-amnesic effects in rats. MF 268 can be used in research related to Alzheimer's disease .
loading...
    loading...